Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein

Steve T. Russell, Thomas P. Zimmerman, Barbara A. Domin, Michael J. Tisdale

Research output: Contribution to journalArticle

Abstract

Loss of adipose tissue in cancer cachexia has been associated with tumour production of a lipid-mobilizing factor (LMF) which has been shown to be homologous with the plasma protein zinc-α2-glycoprotein (ZAG). The aim of this study was to compare the ability of human ZAG with LMF to stimulate lipolysis in vitro and induce loss of body fat in vivo, and to determine the mechanisms involved. ZAG was purified from human plasma using a combination of Q Sepharose and Superdex 75 chromatography, and was shown to stimulate glycerol release from isolated murine epididymal adipocytes in a dose-dependent manner. The effect was enhanced by the cyclic AMP phosphodiesterase inhibitor Ro20-1724, and attenuated by freeze/thawing and the specific β3-adrenoreceptor antagonist SR59230A. In vivo ZAG caused highly significant, time-dependent, decreases in body weight without a reduction in food and water intake. Body composition analysis showed that loss of body weight could be attributed entirely to the loss of body fat. Loss of adipose tissue may have been due to the lipolytic effect of ZAG coupled with an increase in energy expenditure, since there was a dose-dependent increase in expression of uncoupling protein-1 (UCP-1) in brown adipose tissue. These results suggest that ZAG may be effective in the treatment of obesity.

Original languageEnglish
Pages (from-to)59-68
Number of pages10
JournalBBA - Molecular and Cell Biology of Lipids
Volume1636
Issue number1
Early online date19 Feb 2004
DOIs
Publication statusPublished - 27 Feb 2004

Fingerprint

Lipolysis
Adipose Tissue
Zinc
Glycoproteins
Body Weight
Cachexia
Brown Adipose Tissue
Phosphodiesterase Inhibitors
Body Composition
Adipocytes
Cyclic AMP
Sepharose
Glycerol
Energy Metabolism
Drinking
Chromatography
Blood Proteins
Neoplasms
Obesity
Eating

Keywords

  • Cachexia
  • Lipid catabolism
  • Obesity
  • Zinc-α-glycoprotein
  • β3-adrenoreceptor

Cite this

Russell, Steve T. ; Zimmerman, Thomas P. ; Domin, Barbara A. ; Tisdale, Michael J. / Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. In: BBA - Molecular and Cell Biology of Lipids . 2004 ; Vol. 1636, No. 1. pp. 59-68.
@article{8ef98f084cc84f8fbefdca1ecaf7c0b9,
title = "Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein",
abstract = "Loss of adipose tissue in cancer cachexia has been associated with tumour production of a lipid-mobilizing factor (LMF) which has been shown to be homologous with the plasma protein zinc-α2-glycoprotein (ZAG). The aim of this study was to compare the ability of human ZAG with LMF to stimulate lipolysis in vitro and induce loss of body fat in vivo, and to determine the mechanisms involved. ZAG was purified from human plasma using a combination of Q Sepharose and Superdex 75 chromatography, and was shown to stimulate glycerol release from isolated murine epididymal adipocytes in a dose-dependent manner. The effect was enhanced by the cyclic AMP phosphodiesterase inhibitor Ro20-1724, and attenuated by freeze/thawing and the specific β3-adrenoreceptor antagonist SR59230A. In vivo ZAG caused highly significant, time-dependent, decreases in body weight without a reduction in food and water intake. Body composition analysis showed that loss of body weight could be attributed entirely to the loss of body fat. Loss of adipose tissue may have been due to the lipolytic effect of ZAG coupled with an increase in energy expenditure, since there was a dose-dependent increase in expression of uncoupling protein-1 (UCP-1) in brown adipose tissue. These results suggest that ZAG may be effective in the treatment of obesity.",
keywords = "Cachexia, Lipid catabolism, Obesity, Zinc-α-glycoprotein, β3-adrenoreceptor",
author = "Russell, {Steve T.} and Zimmerman, {Thomas P.} and Domin, {Barbara A.} and Tisdale, {Michael J.}",
year = "2004",
month = "2",
day = "27",
doi = "10.1016/j.bbalip.2003.12.004",
language = "English",
volume = "1636",
pages = "59--68",
journal = "BBA - Molecular and Cell Biology of Lipids",
issn = "1388-1981",
publisher = "Elsevier",
number = "1",

}

Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. / Russell, Steve T.; Zimmerman, Thomas P.; Domin, Barbara A.; Tisdale, Michael J.

In: BBA - Molecular and Cell Biology of Lipids , Vol. 1636, No. 1, 27.02.2004, p. 59-68.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein

AU - Russell, Steve T.

AU - Zimmerman, Thomas P.

AU - Domin, Barbara A.

AU - Tisdale, Michael J.

PY - 2004/2/27

Y1 - 2004/2/27

N2 - Loss of adipose tissue in cancer cachexia has been associated with tumour production of a lipid-mobilizing factor (LMF) which has been shown to be homologous with the plasma protein zinc-α2-glycoprotein (ZAG). The aim of this study was to compare the ability of human ZAG with LMF to stimulate lipolysis in vitro and induce loss of body fat in vivo, and to determine the mechanisms involved. ZAG was purified from human plasma using a combination of Q Sepharose and Superdex 75 chromatography, and was shown to stimulate glycerol release from isolated murine epididymal adipocytes in a dose-dependent manner. The effect was enhanced by the cyclic AMP phosphodiesterase inhibitor Ro20-1724, and attenuated by freeze/thawing and the specific β3-adrenoreceptor antagonist SR59230A. In vivo ZAG caused highly significant, time-dependent, decreases in body weight without a reduction in food and water intake. Body composition analysis showed that loss of body weight could be attributed entirely to the loss of body fat. Loss of adipose tissue may have been due to the lipolytic effect of ZAG coupled with an increase in energy expenditure, since there was a dose-dependent increase in expression of uncoupling protein-1 (UCP-1) in brown adipose tissue. These results suggest that ZAG may be effective in the treatment of obesity.

AB - Loss of adipose tissue in cancer cachexia has been associated with tumour production of a lipid-mobilizing factor (LMF) which has been shown to be homologous with the plasma protein zinc-α2-glycoprotein (ZAG). The aim of this study was to compare the ability of human ZAG with LMF to stimulate lipolysis in vitro and induce loss of body fat in vivo, and to determine the mechanisms involved. ZAG was purified from human plasma using a combination of Q Sepharose and Superdex 75 chromatography, and was shown to stimulate glycerol release from isolated murine epididymal adipocytes in a dose-dependent manner. The effect was enhanced by the cyclic AMP phosphodiesterase inhibitor Ro20-1724, and attenuated by freeze/thawing and the specific β3-adrenoreceptor antagonist SR59230A. In vivo ZAG caused highly significant, time-dependent, decreases in body weight without a reduction in food and water intake. Body composition analysis showed that loss of body weight could be attributed entirely to the loss of body fat. Loss of adipose tissue may have been due to the lipolytic effect of ZAG coupled with an increase in energy expenditure, since there was a dose-dependent increase in expression of uncoupling protein-1 (UCP-1) in brown adipose tissue. These results suggest that ZAG may be effective in the treatment of obesity.

KW - Cachexia

KW - Lipid catabolism

KW - Obesity

KW - Zinc-α-glycoprotein

KW - β3-adrenoreceptor

UR - http://www.scopus.com/inward/record.url?scp=1242292263&partnerID=8YFLogxK

UR - https://www.sciencedirect.com/science/article/pii/S1388198103002245?via%3Dihub

U2 - 10.1016/j.bbalip.2003.12.004

DO - 10.1016/j.bbalip.2003.12.004

M3 - Article

VL - 1636

SP - 59

EP - 68

JO - BBA - Molecular and Cell Biology of Lipids

JF - BBA - Molecular and Cell Biology of Lipids

SN - 1388-1981

IS - 1

ER -